/*! elementor – v3.6.5 – 27-04-2022 */
.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}

Aims

This course aims to increase health professionals’ confidence in identifying symptoms of possible chronic leukaemia and support clinical decision making about urgent referral.

Learning Objectives

On completion of this course you will:

• Increase awareness of symptoms and diagnosis of chronic leukaemia
• Understand the different presentations, referral, and management of chronic leukaemia
• Increase confidence in decision making about referral on urgent pathways
• Increase confidence in discussing urgent referral with patients and dealing with angry patients

Outline

The key elements of the course are:

• Facts and figures 
• Chronic Myeloid Leukaemia (CML) presentation
• CML – results and next steps
• Chronic Lymphoblastic Leukaemia (CLL)
• NICE NG12 guidelines
• Summary

There will be access to additional resources throughout the course.  These resources are optional should you want to deepen your knowledge of a particular aspect of the course. However, the time taken to access the resources is not included in the 1-hour time frame given to complete the course.

Contributors

This course was developed by The GatewayC Development Team, with digital and design support being provided by The Christie’s Digital Learning Team.

The following individuals were involved in the development of this course:

/*! elementor – v3.6.5 – 27-04-2022 */
.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}

Professor Adrian Bloor is a Consultant Haematologist at The Christie NHS Foundation Trust. He has a special interest in the management of lymphoid malignancies (CLL and lymphoma), cellular therapies including CAR-T therapy, stem cell transplantation and in clinical trials.

/*! elementor – v3.6.5 – 27-04-2022 */
.e-container.e-container–row .elementor-spacer-inner{width:var(–spacer-size)}.e-container.e-container–column .elementor-spacer-inner,.elementor-column .elementor-spacer-inner{height:var(–spacer-size)}

Dr Steve Tomkinson is a… NEED BIO AND PHOTO

Dr Richard Roope is the Primary Care Adviser for Cancer Research UK and the Wessex Cancer Alliance GP Adviser. With a history of working in the medical practice industry, Dr Roope has a particular interest in the areas of prevention and early diagnosis of cancer together with delivery of cancer care. He has also been the RCGP Clinical Champion for Cancer.

This course is supported by Leukaemia Care.

Copyright and Reviews

All content copyright is owned by The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, United Kingdom

Date of publication: October 2019

Date of last review: December 2021